Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion type Assertion NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_head.
- NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion description "[Moreover, comparing both DS and non-DS AMKL with MK, we identified three potential clinical markers of progression to AMKL: TMEM241 (transmembrane protein 241) was the most over-expressed single gene, while APOC2 (apolipoprotein C-II) and ZNF587B (zinc finger protein 587B) appear to be the most discriminant markers of progression, specifically to DS AMKL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_provenance.
- NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion evidence source_evidence_literature NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_provenance.
- NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion SIO_000772 25476127 NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_provenance.
- NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion wasDerivedFrom befree-2016 NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_provenance.
- NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_assertion wasGeneratedBy ECO_0000203 NP1244920.RA1eZ5dl_y22HWQ3onfY2kQ3iScMoM3x87I5UJaUxdxQc130_provenance.